Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Vanda Pharmaceuticals Inc. (VNDA)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
4 Mar 2024
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
231,014
-5%
14,700
$4.31
$63,392.65
SELL
4 Mar 2024
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
313,569
-5%
17,411
$4.21
$73,378.70
SELL
4 Mar 2024
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
129,789
-11%
16,727
$4.30
$71,921.02
SELL
4 Mar 2024
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer, Chairman of the Board
Vanda Pharmaceuticals Inc.
(VNDA)
1,871,730
-2%
55,172
$4.19
$231,338.53
SELL
4 Mar 2024
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
196,825
-7%
17,088
$4.29
$73,312.59
SELL
21 Aug 2023
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
113,816
-3%
3,724
$5.84
$21,748.16
SELL
10 Aug 2023
Mitchell Stephen Ray
Director
Vanda Pharmaceuticals Inc.
(VNDA)
29,328
-18%
6,500
$6.05
$39,349.05
SELL
28 Jul 2023
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
122,514
-1%
2,212
$6.30
$13,944.60
SELL
15 Jun 2023
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
122,926
-11%
16,000
$6.29
$100,710.41
SELL
13 Jun 2023
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
88,913
-14%
14,600
$6.56
$95,754.09
SELL
2 Mar 2023
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
138,926
-9%
13,934
$6.27
$87,344.39
SELL
2 Mar 2023
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
205,980
-7%
16,777
$6.23
$104,583.98
SELL
2 Mar 2023
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
103,513
-13%
16,738
$6.25
$104,571.91
SELL
2 Mar 2023
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
117,540
-9%
11,833
$6.26
$74,116.78
SELL
2 Mar 2023
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer, Chairman of the Board
Vanda Pharmaceuticals Inc.
(VNDA)
1,476,902
-2%
44,964
$6.24
$280,594.50
SELL
15 Dec 2022
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
87,551
-8%
8,000
$7.01
$56,069.60
SELL
6 Dec 2022
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
120,160
-3%
4,792
$10.61
$50,826.83
SELL
5 Dec 2022
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer, Chairman of the Board
Vanda Pharmaceuticals Inc.
(VNDA)
1,406,866
-6%
95,900
$10.62
$1,018,282.25
SELL
22 Aug 2022
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
96,673
-3%
3,605
$10.27
$37,007.49
SELL
13 Jun 2022
Mitchell Stephen Ray
Director
Vanda Pharmaceuticals Inc.
(VNDA)
6,515
-29%
2,700
$9.48
$25,593.03
SELL
2 Jun 2022
Watkins Thomas
Director
Vanda Pharmaceuticals Inc.
(VNDA)
63,064
-9%
6,441
$9.90
$63,778.79
SELL
31 May 2022
DUGAN RICHARD W
Director
Vanda Pharmaceuticals Inc.
(VNDA)
68,387
-8%
6,500
$9.85
$64,052.30
SELL
28 Feb 2022
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer, Chairman of the Board
Vanda Pharmaceuticals Inc.
(VNDA)
1,352,766
-2%
37,096
$11.16
$413,959.20
SELL
28 Feb 2022
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
103,851
-10%
12,060
$11.09
$133,779.17
SELL
28 Feb 2022
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
100,278
-6%
6,974
$11.19
$78,059.98
SELL
28 Feb 2022
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
119,691
-9%
12,305
$11.26
$138,512.56
SELL
28 Feb 2022
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
188,807
-7%
15,601
$11.25
$175,491.94
SELL
30 Nov 2021
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,274,862
-7%
96,200
$16.25
$1,563,622.90
SELL
15 Sep 2021
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
81,980
-17%
16,824
$16.49
$277,394.12
SELL
9 Sep 2021
Mitchell Stephen Ray
Director
Vanda Pharmaceuticals Inc.
(VNDA)
9,215
-67%
19,109
$16.74
$319,976.40
SELL
20 Aug 2021
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
74,552
-4%
3,650
$15.39
$56,189.56
SELL
16 Aug 2021
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
83,211
-4%
3,715
$16.15
$59,988.70
SELL
28 Jul 2021
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
99,296
-2%
2,130
$19.24
$40,972.89
SELL
26 Jul 2021
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
86,685
-7%
7,250
$19.69
$142,776.42
SELL
15 Jun 2021
Mitchell Stephen Ray
Director
Vanda Pharmaceuticals Inc.
(VNDA)
9,215
-35%
5,000
$19.42
$97,122.00
SELL
14 Jun 2021
Chrousos Phaedra
Director
Vanda Pharmaceuticals Inc.
(VNDA)
12,925
-13%
2,075
$19.34
$40,132.16
SELL
15 Mar 2021
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
93,935
-16%
18,000
$17.72
$319,010.38
SELL
8 Mar 2021
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,221,062
-12%
175,000
$18.00
$3,150,052.50
SELL
5 Mar 2021
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
92,326
-5%
5,600
$17.85
$99,966.00
SELL
2 Mar 2021
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
96,935
-3%
3,865
$18.04
$69,717.25
SELL
2 Mar 2021
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
78,202
-4%
3,888
$18.45
$71,728.93
SELL
1 Mar 2021
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,396,062
-1%
22,685
$18.38
$416,904.88
SELL
1 Mar 2021
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
92,526
-17%
19,530
$18.58
$362,850.38
SELL
1 Mar 2021
Moran Kevin Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
101,426
-8%
9,371
$18.35
$171,970.64
SELL
1 Mar 2021
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
171,708
-10%
20,465
$18.28
$374,016.75
SELL
24 Feb 2021
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
100,800
-18%
22,986
$20.01
$460,032.60
SELL
16 Feb 2021
DUGAN RICHARD W
Director
Vanda Pharmaceuticals Inc.
(VNDA)
54,887
-9%
5,754
$18.54
$106,663.06
SELL
16 Feb 2021
Watkins Thomas
Director
Vanda Pharmaceuticals Inc.
(VNDA)
49,505
-10%
5,818
$18.54
$107,855.83
SELL
11 Dec 2020
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,303,747
-8%
125,252
$13.04
$1,633,510.00
SELL
20 Aug 2020
Wijkstrom Joakim
SVP, Chief Marketing Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
56,290
-6%
3,710
$11.08
$41,109.02
SELL
14 Aug 2020
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
79,356
-4%
3,684
$11.81
$43,526.09
SELL
12 Aug 2020
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
75,487
-8%
7,200
$11.81
$85,018.32
SELL
27 Jul 2020
Jones Aranthan II
Chief Corp. Affairs Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
82,687
-8%
7,313
$10.62
$77,631.16
SELL
29 May 2020
Watkins Thomas
Director
Vanda Pharmaceuticals Inc.
(VNDA)
35,323
-21%
9,677
$11.50
$111,285.50
SELL
28 May 2020
DUGAN RICHARD W
Director
Vanda Pharmaceuticals Inc.
(VNDA)
40,641
-19%
10,129
$11.04
$111,805.93
SELL
2 Mar 2020
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,278,999
-1%
15,580
$10.70
$166,755.67
SELL
2 Mar 2020
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
83,040
-5%
4,385
$10.36
$45,439.57
SELL
2 Mar 2020
Reverberi Gian Piero
SVP & Chief Commercial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
165,384
-0%
1,450
$10.18
$14,755.20
SELL
2 Mar 2020
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
159,473
-10%
17,758
$10.23
$181,670.20
SELL
2 Mar 2020
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
186,869
-9%
18,857
$10.36
$195,446.02
SELL
2 Jan 2020
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,234,579
-0%
9,467
$16.00
$151,492.81
SELL
2 Jan 2020
Reverberi Gian Piero
SVP & Chief Commercial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
166,834
-0%
1,155
$16.06
$18,550.69
SELL
2 Jan 2020
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
147,231
-2%
4,020
$15.93
$64,021.32
SELL
2 Jan 2020
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
205,726
-1%
4,020
$15.94
$64,086.04
SELL
11 Dec 2019
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,244,046
-10%
142,409
$16.95
$2,413,729.00
SELL
26 Aug 2019
DUGAN RICHARD W
Director
Vanda Pharmaceuticals Inc.
(VNDA)
35,770
-29%
15,000
$14.85
$222,750.00
SELL
14 Aug 2019
Williams Timothy
SVP & General Counsel, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
57,425
-4%
2,575
$14.69
$37,829.32
SELL
17 May 2019
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,211,455
-15%
217,515
$15.35
$3,338,725.50
SELL
1 Mar 2019
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,178,970
-3%
44,666
$19.53
$872,225.56
SELL
1 Mar 2019
Reverberi Gian Piero
SVP & Chief Commercial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
167,989
-0%
881
$20.04
$17,655.06
SELL
1 Mar 2019
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
151,251
-7%
12,529
$19.96
$250,092.00
SELL
1 Mar 2019
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
209,746
-6%
13,727
$19.98
$274,232.50
SELL
2 Jan 2019
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,163,636
-1%
15,236
$26.36
$401,662.70
SELL
2 Jan 2019
Reverberi Gian Piero
SVP & Chief Commercial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
139,400
-0%
1,130
$26.59
$30,042.35
SELL
2 Jan 2019
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
133,780
-4%
6,061
$26.37
$159,809.94
SELL
2 Jan 2019
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
193,473
-3%
6,061
$26.37
$159,810.78
SELL
28 Feb 2018
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,182,872
-4%
60,966
$18.72
$1,141,003.10
SELL
28 Feb 2018
Gulino Richard L.
SVP, General Counsel & Sec., Officer
Vanda Pharmaceuticals Inc.
(VNDA)
115,073
-3%
3,660
$18.71
$68,473.11
SELL
28 Feb 2018
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
139,841
-5%
8,525
$18.72
$159,605.05
SELL
28 Feb 2018
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
199,534
-4%
8,532
$18.72
$159,712.22
SELL
2 Jan 2018
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
1,111,623
-14%
191,760
$15.30
$2,933,126.80
SELL
2 Jan 2018
Gulino Richard L.
SVP, General Counsel & Sec., Officer
Vanda Pharmaceuticals Inc.
(VNDA)
88,733
-10%
10,367
$15.20
$157,564.92
SELL
2 Jan 2018
Birznieks Gunther
SVP, Business Development, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
118,366
-6%
8,568
$15.26
$130,776.81
SELL
2 Jan 2018
Kelly James Patrick
EVP & Chief Financial Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
168,066
-5%
9,155
$15.35
$140,493.55
SELL
3 Jan 2017
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
850,848
-2%
23,330
$15.48
$361,241.72
SELL
3 Jan 2017
Gulino Richard L.
SVP, General Counsel & Sec., Officer
Vanda Pharmaceuticals Inc.
(VNDA)
9,100
-54%
10,900
$15.51
$169,089.52
BUY
3 Jan 2017
Baroldi Paolo
SVP & Chief Medical Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
54,365
+42%
16,300
$15.51
$252,775.52
SELL
3 Jan 2017
Kelly James Patrick
SVP, CFO & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
69,721
-13%
10,895
$15.51
$169,013.05
SELL
22 Sep 2016
Flynn James E
10% Owner, Possible Member of 10% Group
Vanda Pharmaceuticals Inc.
(VNDA)
1,599,476
-41%
1,120,461
$16.56
$18,559,970.00
SELL
15 Sep 2016
Flynn James E
10% Owner, Possible Member of 10% Group
Vanda Pharmaceuticals Inc.
(VNDA)
1,992,798
-21%
547,886
$15.66
$8,582,620.00
SELL
4 Jan 2016
Polymeropoulos Mihael Hristos
President and CEO, Director, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
839,178
-2%
21,353
$8.96
$191,322.88
SELL
4 Jan 2016
Baroldi Paolo
SVP & Chief Medical Officer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
40,665
-23%
12,380
$8.96
$110,924.80
SELL
4 Jan 2016
Kelly James Patrick
SVP, CFO, Sec & Treasurer, Officer
Vanda Pharmaceuticals Inc.
(VNDA)
60,772
-13%
9,564
$8.96
$85,693.44
Home